Similarly, in hepatic failure mice, suppression of the IL-6/STAT3 signaling pathway has been associated with a substantial alleviation in both liver injury and inflammatory responses, as well as a decrease in AST and ALT levels [31]. Here, STAT3 is linked to liver failure.